MedicarePartD.guide

A non-government resource built from CMS public data

Kisqali on AARP Medicare Rx Preferred from UHC (S5921-405)

ribociclib

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 21 per 21 days.

$3,177.06
Patient pays / month, after deductible
$3,266.76
Patient pays / month, before the $130.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

KISQALI 200 mg Tablet, Film Coated at a preferred retail pharmacy, from the plan's negotiated price of $10,248.59 for a month. Other covered strengths are listed below.

Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
FormTierPatient pays / monthLimits
KISQALI 200 mg Tablet, Film Coated5$3,177.06PA · 21 per 21 days
KISQALI 200 mg Tablet, Film Coated5$6,354.14PA · 42 per 21 days
KISQALI 200 mg Tablet, Film Coated5$7,976.52PA · 63 per 21 days

Other CDK4/6 inhibitors on this plan

Verify with the plan before prescribing or filling. Member services: (866)870-3470. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5921-405